Broken Coast Cannabis, a subsidiary of Aphria Inc., received a license amendment from Health Canada for its Phase III expansion. Health Canada provided the company with an added 18,000 sq. ft of production space. This addition brought the production area up to 44,000 sq. ft. Due to this, the production capacity of the unit will touch 4,500 kgs annually.
The Health Canada license amendment is a part of the Access to Cannabis for Medical Purposes Regulations Act (ACMPR).
The company is excited to ramp up its production of high-quality premium buds. The co-founder of Broken Coast expects the first crop cultivated and produced at the expansion to be available for sale by the end of July.
Broken Coast is a Vancouver-based, fully-licensed indoor cannabis proon facility. It provides medicinal cannabis to the Canadian market through the federal ACMPR. It is a prominent and most sought-after cannabis brand in the country. It is also a significant part of Aphria and its portfolio of brands. Aphria Inc. acquired the company at the beginning of this year.
Aphria Inc. is a licensed Canadian producer, supplier, and distributor of medical cannabis. It is located in Leamington, Ontario. The company aims to provide Canadians with superior treatments through its pharmaceutical-grade medical cannabis.
The expansion has doubled Broken Coast’s production capacity. The company plans to use the increase in production to serve the rising demand for cannabidiol. The Canadian market is surging with the introduction of cannabis in various industries. CBD infused beverages, food, cosmetics, and lifestyle products are all set to enter the mainstream. This, in turn, is offering a plethora of opportunities for Broken Coast to thrive on.